Pneumonitis is a potentially serious irAE and is more frequently seen with anti–PD-1 agents, specifically in patients with NSCLC, possibly due to chronic lung inflammation (Hamid et al., 2013b; Garon et al., 2013). Here, PDCD1 is linked to pneumonitis.